Recruiting
Phase 2

VAX-31

Sponsor:

Vaxcyte, Inc.

Code:

NCT06720038

Conditions

Pneumococcal Vaccines

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Accepted

Interventions

0.5 mL of the low dose VAX-31

0.5 mL of the mid dose VAX-31

0.5 mL of the high dose VAX-31

0.5 mL dose of PCV20

0.5 mL of the High-PFS dose VAX-31

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-10. This information was provided to ClinicalTrials.gov by Vaxcyte, Inc. on 2025-10-02.